Navigation Links
Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference
Date:9/17/2008

levels. We are evaluating our lead MEK inhibitor, RDEA119, in a Phase 1 study in advanced cancer patients, and have completed a Phase 1 study in normal healthy volunteers as a precursor to trials in patients with inflammatory diseases. Lastly, we have evaluated our second-generation MEK inhibitor for the treatment of cancer and inflammatory diseases, RDEA436, in a human micro-dose pharmacokinetic study and have selected it for clinical development.

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding our goals, including the expected properties and benefits of RDEA806, RDEA427, RDEA594, RDEA119, RDEA436 and our other compounds and the results of preclinical, clinical and other studies. Risks that contribute to the uncertain nature of the forward- looking statements include: risks related to the outcome of preclinical and clinical studies, risks related to regulatory approvals, delays in commencement of preclinical and clinical studies, and costs associated with our drug discovery and development programs and business development activities. These and other risks and uncertainties are described more fully in our most recently filed SEC documents, including our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q, under the headings "Risk Factors." All forward-looking statements contained in this press release speak only as of the date on which they were made. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.


'/>"/>
SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
2. Ardea Biosciences Announces Changes to Research Management
3. Ardea Biosciences, Inc. Reports Third Quarter 2007 Operating and Financial Results
4. Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference
5. Ardea Biosciences Announces $40 Million Private Placement
6. Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections
7. Ardea Biosciences Establishes Scientific Advisory Board for HIV Program
8. Ardea Biosciences to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
9. Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program
10. Ardea Biosciences to Move Headquarters and R&D Laboratories to San Diego
11. Ardea to Present at Cowen and Companys 28th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 7, 2015 Summary ... Market Analysis" report is an essential source of ... Using detailed company data, deal analysis, corporate strategy, ... analysis of the current and future growth drivers ... the key factors shaping and driving the gene ...
(Date:7/7/2015)... Genes in Space, a nation-wide scientific ... at New England Biolabs® (NEB®) along with the ... exploration and celebration, on Thursday, July 9 th ... The Center for Advancement of Science in Space, ... design an experiment to solve a real-life space ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... for biologic are some of the factors driving the pharmaceutical contract manufacturing market. ... as well as contract manufacturing organizations (CMOs), are driving market growth. Drug manufacturers ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... and a subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its ... technical validation and self declaration under the European Directive for In Vitro Diagnostic ...
Breaking Biology Technology:PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis 2Genes in Space finalists attend laboratory workshop and celebration at New England Biolabs' headquarters 2More Drug Companies Increasing Outsourcing Budgets; CMO Partners Spring Up as Market Thrives, According to BCC Research 2More Drug Companies Increasing Outsourcing Budgets; CMO Partners Spring Up as Market Thrives, According to BCC Research 3DNA Genotek Inc. Receives CE-IVD Mark for its OMNIgene®•GUT Microbiome Collection Kit 2
... April 1, 2011 Optimer Pharmaceuticals, Inc. (NASDAQ: ... Compensation Committee of its Board of Directors approved the grant ... shares of common stock to 7 new employees. ... an exercise price per share equal to $11.83, the fair ...
... principles of quantum mechanics apply to biological systems? Until ... Physics Department (Faculty of Chemistry), both biologists and physicists ... like apples and oranges. But research he conducted together ... Science , definitively shows that a biological molecule ...
... Technology (NIST) have developed a way to measure the wear ... structures in situ and as it,s happening. Their technique can ... most precise and delicate nanoscale measurements done with atomic force ... of a surface with a ruler that,s crumbling away as ...
Cached Biology Technology:Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 2Biological molecules select their spin 2Getting the point: Real-time monitoring of atomic-microscope probes adjusts for wear 2
(Date:7/7/2015)... , June 30, 2015 ... announced the addition of the "Capacitive Fingerprint ... To this date, fingerprint sensing technology ... and fingerprint sensors are well developed. This patent ... technology. The domain of capacitive fingerprint ...
(Date:7/7/2015)... , July 7, 2015  Based on ... Frost & Sullivan recognizes Credence ID, LLC with ... Entrepreneurial Company of the Year Award. Credence ID ... aid in its mission of offering enrollment and ... globally. As Credence ID was formed by experts ...
(Date:7/7/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... commerce market announces a revised version of one of its first ... air on CNBC in New York , ... San Francisco metro areas.    ... ability to replace all the cards in your wallet and keep ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... expedition in Australia and New Zealand to find the rare ... researchers to confirm new developmental similarities between fish and mammals. ... same genetic process for forming skeletal gill covers that lizards ... the University of Chicago and the University of Cambridge found. ...
... an essential nutrientironis scarce, a marine bacterium that launches the ... It recycles iron. By day, it uses iron in ... appears to reuse the same iron in different enzymes to ... watsonii , is one of the few marine microbes that ...
... NY, January 10, 2011The mega-mergers of 2009 did not continue ... had a price tag of more than $40 billion, only ... an evaluation of reported deals conducted by Genetic Engineering & ... takeover for the year, sanofi-aventis, move to buy Genzyme, is ...
Cached Biology News:Hard-to-find fish reveals shared developmental toolbox of evolution 2Hard-to-find fish reveals shared developmental toolbox of evolution 3'Hot-bunking' bacterium recycles iron to boost ocean metabolism 2'Hot-bunking' bacterium recycles iron to boost ocean metabolism 3GEN reports on biotech acquisition deals in 2010 that topped $1 billion 2
... This kit allows for quick and reproducible ... plate. The system is more reproducible than regular ... the protein A/G agarose without disrupting the agarose ... Catch and Release is reversible, and elution of ...
... Oligo Microarray Kit (V2), 2 x ... characterize expression of many thousands of ... during important biological processes. Each microarray ... known ORFs from the S288C strain ...
... Successful biomarker discovery projects require screening ... to distinguish clinically relevant data from ... Data Manager is now available to ... tracking and data flood inherent to ...
... Immunoprecipitation kit allows a rapid and ... active FLAG-tagged protein. The immunoprecipitation is ... is a highly specific monoclonal antibody ... use of affinity resin allows an ...
Biology Products: